However, only indicators clinically highly accessible and generally representing inflammation were included in the current study, and thus more specific inflammatory indicators, such as interleukin, tumor necrosis factor, etc., should be examined in further studies, to explore the inflammation characteristic with the transformation from NAFLD to MAFLD. This evidence concerns the gene TNF and metabolic dysfunction-associated steatotic liver disease.